FDA Inspection
New York Blood Center EnterprisesNew York Blood Center Enterprises – FDA Inspection, Jul 8, 2026
Record Details
This FDA Inspection record concerns New York Blood Center Enterprises, with an inspection on July 8, 2026, issued by the New York District Office, covering biologics.
View Company Profile
ID · 3b7efb82-7594-4c1c-aa71-d9bfa64ec8ff
Inspection Facts
- Inspection number
- 1325696
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.160(a)(1)Concurrent documentation
- 21 CFR 606.160(b)Required records
- 21 CFR 606.60(a)Maintain and clean equipment
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center Enterprises
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 25, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 22, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 29, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 1, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center Enterprises
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.